JG
ABEO icon

Jefferies Group’s Abeona Therapeutics ABEO Stock Holding History

Jefferies Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-504
Closed -$60K – 2659
2019
Q2 		$60K Sell
504
-42
-8% -$7.04K ﹤0.01% 2351
2019
Q1 		$100K Sell
546
-18
-3% -$3.22K ﹤0.01% 2115
2018
Q4 		$101K Buy
+564
New +$123K ﹤0.01% 1959
2017
Q3 		– Sell
-576
Closed -$92K – 2287
2017
Q2 		$92K Buy
+576
New +$78.6K ﹤0.01% 2090
2017
Q1 		– Sell
-1,000
Closed -$121K – 2274
2016
Q4 		$121K Sell
1,000
-400
-29% -$62.6K ﹤0.01% 1994
2016
Q3 		$210K Buy
+1,400
New +$137K ﹤0.01% 1927

Other funds holding ABEO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Group's ABEO Position: Q3 2019 in Review

Jefferies Group sold out of Abeona Therapeutics (ABEO) in Q3 2019, closing a stake of 504 shares — an estimated $60K sold.

Jefferies Group first reported a position in ABEO in Q3 2016 and held it in 6 quarters. The position peaked at $210K in Q3 2016. 79 funds tracked by Wall St. Rank hold ABEO as of Q3 2019.

  • Jefferies Group reported no remaining Abeona Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 504 Abeona Therapeutics shares in Q3 2019, an estimated $60K.
  • Jefferies Group first reported a position in Abeona Therapeutics in Q3 2016 and held it in 6 quarters.
  • Jefferies Group's Abeona Therapeutics position peaked at $210K in Q3 2016.
  • 79 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.